| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| P-Y Le Bec, M Fatséas, C Denis, E Lavie, M Auriacomb. [Cannabis and psychosis: search of a causal link through a critical and systematic review]. L'Encephale. vol 35. issue 4. 2009-11-02. PMID:19748375. |
in particular, because of the frequent co-occurrence between schizophrenia and cannabis use, the question has been raised of a causal link between exposure to cannabis as a risk factor and the development of psychosis or psychotic symptoms. |
2009-11-02 |
2023-08-12 |
Not clear |
| Rachel Miller, Geoffrey Ream, Joanne McCormack, Handan Gunduz-Bruce, Serge Sevy, Delbert Robinso. A prospective study of cannabis use as a risk factor for non-adherence and treatment dropout in first-episode schizophrenia. Schizophrenia research. vol 113. issue 2-3. 2009-10-29. PMID:19481424. |
a prospective study of cannabis use as a risk factor for non-adherence and treatment dropout in first-episode schizophrenia. |
2009-10-29 |
2023-08-12 |
Not clear |
| Rachel Miller, Geoffrey Ream, Joanne McCormack, Handan Gunduz-Bruce, Serge Sevy, Delbert Robinso. A prospective study of cannabis use as a risk factor for non-adherence and treatment dropout in first-episode schizophrenia. Schizophrenia research. vol 113. issue 2-3. 2009-10-29. PMID:19481424. |
although several studies have reported on cannabis use and adherence for first episode of psychosis patients, the findings remain unclear as to whether cannabis use is a risk factor for poor adherence in young people with first-episode schizophrenia. |
2009-10-29 |
2023-08-12 |
Not clear |
| Martin Frisher, Ilana Crome, Orsolina Martino, Peter Crof. Assessing the impact of cannabis use on trends in diagnosed schizophrenia in the United Kingdom from 1996 to 2005. Schizophrenia research. vol 113. issue 2-3. 2009-10-29. PMID:19560900. |
assessing the impact of cannabis use on trends in diagnosed schizophrenia in the united kingdom from 1996 to 2005. |
2009-10-29 |
2023-08-12 |
Not clear |
| Martin Frisher, Ilana Crome, Orsolina Martino, Peter Crof. Assessing the impact of cannabis use on trends in diagnosed schizophrenia in the United Kingdom from 1996 to 2005. Schizophrenia research. vol 113. issue 2-3. 2009-10-29. PMID:19560900. |
furthermore, a model of the association between cannabis use and schizophrenia indicated that the incidence and prevalence of schizophrenia would increase from 1990 onwards. |
2009-10-29 |
2023-08-12 |
Not clear |
| Paul R A Stokes, Mitul A Mehta, H Valerie Curran, Gerome Breen, Paul M Grasb. Can recreational doses of THC produce significant dopamine release in the human striatum? NeuroImage. vol 48. issue 1. 2009-10-26. PMID:19539765. |
cannabis use in early adolescence may be a risk factor for development of schizophrenia. |
2009-10-26 |
2023-08-12 |
human |
| Gisela Sugranyes, Itziar Flamarique, Eduard Parellada, Immaculada Baeza, Javier Goti, Emilio Fernandez-Egea, Miquel Bernard. Cannabis use and age of diagnosis of schizophrenia. European psychiatry : the journal of the Association of European Psychiatrists. vol 24. issue 5. 2009-09-14. PMID:19324529. |
cannabis use and age of diagnosis of schizophrenia. |
2009-09-14 |
2023-08-12 |
Not clear |
| Gisela Sugranyes, Itziar Flamarique, Eduard Parellada, Immaculada Baeza, Javier Goti, Emilio Fernandez-Egea, Miquel Bernard. Cannabis use and age of diagnosis of schizophrenia. European psychiatry : the journal of the Association of European Psychiatrists. vol 24. issue 5. 2009-09-14. PMID:19324529. |
we aimed to examine whether cannabis use determined an earlier onset of schizophrenia in a sample of first episode patients, in an area with one of europe's highest rates of cannabis use. |
2009-09-14 |
2023-08-12 |
Not clear |
| Thomas Schnell, Dagmar Koethe, Jörg Daumann, Euphrosyne Gouzoulis-Mayfran. The role of cannabis in cognitive functioning of patients with schizophrenia. Psychopharmacology. vol 205. issue 1. 2009-09-02. PMID:19326102. |
the role of cannabis in cognitive functioning of patients with schizophrenia. |
2009-09-02 |
2023-08-12 |
Not clear |
| Thomas Schnell, Dagmar Koethe, Jörg Daumann, Euphrosyne Gouzoulis-Mayfran. The role of cannabis in cognitive functioning of patients with schizophrenia. Psychopharmacology. vol 205. issue 1. 2009-09-02. PMID:19326102. |
cognitive deficits are commonly found both in patients with schizophrenia (sch) and in people with cannabis use disorders (cud). |
2009-09-02 |
2023-08-12 |
Not clear |
| R Andrew Sewell, Mohini Ranganathan, Deepak Cyril D'Souz. Cannabinoids and psychosis. International review of psychiatry (Abingdon, England). vol 21. issue 2. 2009-08-04. PMID:19367509. |
cross-sectional studies document an association between cannabis use and psychotic symptoms, and longitudinal studies suggest that early exposure to cannabis confers a close to two-fold increase in the risk of developing schizophrenia. |
2009-08-04 |
2023-08-12 |
Not clear |
| R Andrew Sewell, Mohini Ranganathan, Deepak Cyril D'Souz. Cannabinoids and psychosis. International review of psychiatry (Abingdon, England). vol 21. issue 2. 2009-08-04. PMID:19367509. |
it is likely that cannabis exposure is a 'component cause' that interacts with other factors to 'cause' schizophrenia or other psychotic disorder, but is neither necessary nor sufficient to do so alone. |
2009-08-04 |
2023-08-12 |
Not clear |
| Patrik Roser, Jürgen Gallinat, Gordon Weinberg, Georg Juckel, Inge Gorynia, Andreas M Stadelman. Psychomotor performance in relation to acute oral administration of Delta9-tetrahydrocannabinol and standardized cannabis extract in healthy human subjects. European archives of psychiatry and clinical neuroscience. vol 259. issue 5. 2009-07-01. PMID:19224107. |
cannabis extract, but not delta(9)-thc, revealed a significant reduction of right-hand tapping frequencies that was also found in schizophrenia. |
2009-07-01 |
2023-08-12 |
human |
| Sagnik Bhattacharyya, Paolo Fusar-Poli, Stefan Borgwardt, Rocio Martin-Santos, Chiara Nosarti, Colin O'Carroll, Paul Allen, Marc L Seal, Paul C Fletcher, José A Crippa, Vincent Giampietro, Andrea Mechelli, Zerrin Atakan, Philip McGuir. Modulation of mediotemporal and ventrostriatal function in humans by Delta9-tetrahydrocannabinol: a neural basis for the effects of Cannabis sativa on learning and psychosis. Archives of general psychiatry. vol 66. issue 4. 2009-04-22. PMID:19349314. |
cannabis sativa use can impair verbal learning, provoke acute psychosis, and increase the risk of schizophrenia. |
2009-04-22 |
2023-08-12 |
human |
| Miguel Ruiz-Veguilla, Manuel Gurpegui, María Luisa Barrigón, Maite Ferrín, Esther Marín, José Luis Rubio, Blanca Gutiérrez, Antonio Pintor, Jorge Cervill. Fewer neurological soft signs among first episode psychosis patients with heavy cannabis use. Schizophrenia research. vol 107. issue 2-3. 2009-04-20. PMID:18805673. |
although neurological soft signs (nss) have been consistently associated with schizophrenia and a variety of risk factors, few studies have focused on the association between nss and environmental factors such as cannabis use, particularly in patients with first episode psychosis. |
2009-04-20 |
2023-08-12 |
Not clear |
| Chad R Edwards, Patrick D Skosni. Cerebellar-dependent learning as a neurobehavioral index of the cannabinoid system. Critical reviews in neurobiology. vol 19. issue 1. 2009-04-14. PMID:19166390. |
finally, the implications of the model is discussed in consideration of recent evidence from cb1 knockout mice, human cannabis users, and schizophrenia patients, with the expectation that translational research on the cannabinoid system will be advanced. |
2009-04-14 |
2023-08-12 |
mouse |
| Sonija Luzi, Paul D Morrison, John Powell, Marta di Forti, Robin M Murra. What is the mechanism whereby cannabis use increases risk of psychosis? Neurotoxicity research. vol 14. issue 2-3. 2009-03-31. PMID:19073418. |
it is well known that cannabis intoxication can cause brief psychotic symptoms like paranoia, whilst recent evidence demonstrates that heavy use of cannabis increases the risk of chronic psychoses like schizophrenia; genetic vulnerability seems to predispose some people to a higher risk. |
2009-03-31 |
2023-08-12 |
Not clear |
| Michael Schaub, Kyra Fanghaenel, Charlotte Senn, Rudolf Stohle. Cannabis using schizophrenia patients treated with atypical neuroleptics: do their symptoms differ from those of cannabis abstainers? Substance use & misuse. vol 43. issue 14. 2009-03-10. PMID:19085437. |
cannabis using schizophrenia patients treated with atypical neuroleptics: do their symptoms differ from those of cannabis abstainers? |
2009-03-10 |
2023-08-12 |
Not clear |
| Michael Schaub, Kyra Fanghaenel, Charlotte Senn, Rudolf Stohle. Cannabis using schizophrenia patients treated with atypical neuroleptics: do their symptoms differ from those of cannabis abstainers? Substance use & misuse. vol 43. issue 14. 2009-03-10. PMID:19085437. |
since differing symptoms could also result from a tn-cannabis combination and might not be due to cannabis use per se, this study examined schizophrenia symptoms in a group of cannabis-using outpatients treated with atypical antipsychotics. |
2009-03-10 |
2023-08-12 |
Not clear |
| Michael Schaub, Kyra Fanghaenel, Charlotte Senn, Rudolf Stohle. Cannabis using schizophrenia patients treated with atypical neuroleptics: do their symptoms differ from those of cannabis abstainers? Substance use & misuse. vol 43. issue 14. 2009-03-10. PMID:19085437. |
forty-two schizophrenia outpatients participated and were divided into three groups: cannabis abstainers, moderate users, and daily users. |
2009-03-10 |
2023-08-12 |
Not clear |